3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
5
Prostatic Neoplasms
3
Melanoma
2
Urinary Bladder Neoplasms
1
Spondylitis, Ankylosing
1
Skin Carcinoma
1
Signs and Symptoms
1
Rectal Neoplasms
1
Psoriasis
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Motor Activity
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lymphedema
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Bowel Diseases
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Endometrial Neoplasms
1
Crohn Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Colitis, Ulcerative
1
Interventions
Specimen Handling
38
Biopsy
30
Magnetic Resonance Spectroscopy
24
pembrolizumab
14
trastuzumab deruxtecan
8
Radiosurgery
8
Nivolumab
8
Gemcitabine
8
Paclitaxel
7
Ipilimumab
6
Carboplatin
6
Capecitabine
6
palbociclib
5
X-Rays
5
Taxes
5
Radiation
5
Leucovorin
5
Fulvestrant
5
Fluorouracil
5
Pemetrexed
4
Oxaliplatin
4
Letrozole
4
Irinotecan
4
CTLA-4 Antigen
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
ribociclib
3
olaparib
3
ipatasertib
3
enzalutamide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Methods
×
30 days
×
Clear all
NCT04960787
2026-05-14
CREDIT
SWOG Cancer Research Network
Phase NA
Active not recruiting
331 enrolled